<DOC>
	<DOCNO>NCT00856999</DOCNO>
	<brief_summary>The purpose study see consistent treatment Botox lead longer lasting effect . Botox injectable liquid approve U.S. Food Drug Administration reduce wrinkle forehead area eyebrow . In study different dose schedule Botox injection use see effect Botox treatment last long effect standard injection regimen .</brief_summary>
	<brief_title>Botox Cosmetic Young Patient With Glabellar Furrows</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<criteria>Female Fitzpatrick Skin Types IIII Between 30 50 year age At least moderate severity maximum frown Prior botulinum toxin treatment Any disorder ( myasthenia gravis , EatonLambert syndrome ) agent ( aminoglycoside antibiotic ) might interfere neuromuscular function Any condition situation might put subject significant risk , confound study result ( significant preexisting brow eyelid ptosis ) Allergy sensitivity study component Participation another clinical study within 30 day study start date Are plan facial cosmetic procedure study period , pregnant , breastfeeding , plan pregnancy study .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Glabellar line moderate severity maximum frown</keyword>
</DOC>